Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model | Zendy

Simon D. Baines | Zendy; Rory O’Connor | Zendy; G. S. Huscroft | Zendy; Katherine Saxton | Zendy; Jane Freeman | Zendy; Mark H. Wilcox | Zendy

Open Access

Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model

Author(s) -

Simon D. Baines,

Rory O’Connor,

G. S. Huscroft,

Katherine Saxton,

Jane Freeman,

Mark H. Wilcox

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp017

Subject(s) - streptococcus pneumoniae , microbiology and biotechnology , levofloxacin , antimicrobial , clostridium difficile , mecillinam , virology , biology , medicine , antibiotics , enterobacteriaceae , biochemistry , escherichia coli , gene

levofloxacin-resistant Streptococcus pneumoniae: a case–control study. Clin Infect Dis 2001; 32: 701–7. 6. Davies TA, Yee YC, Bush K et al. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae. Microb Drug Resist 2008; 14: 187–96. 7. Ho PL, Que TL, Chiu SS et al. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995–2001. Emerg Infect Dis 2004; 10: 1250–7.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research